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Objective: To determine if lumbosacral transforaminal epidural
steroid injection (LTFESI) is as effective in treating lumbosacral
radicular pain in obese (body mass index [BMI] 30) and over-
weight (25BMI30) population compared with the nonover-
weight (18.5BMI25) population, because BMI has not been
described as a prognostic indicator with regard to LTFESI out-
comes.
Design: Retrospective, case control pilot study.
Setting: Major metropolitan urban academic spine and sports
clinic.
Participants: Patients who were not overweight (n9), over-
weight (n9), and obese (n6) presented with lumbosacral radic-
ular pain and received a LTFESI.
Interventions: Fluoroscopically guided contrast-enhanced
LTFESI.
Main Outcome Measures: 11-point pain intensity numeric
rating scale scores were recorded before LTFESI and at an average
follow-up interval of 4 weeks. We determined the mean percentage
reduction in pain and the proportion of individuals with a 50% or
greater reduction in pain in the 3 BMI groups.
Results: No significant differences were found between the normal
BMI group and higher BMI groups with regard to percentage im-
provement in pain (P.7154, P.4566) or in the proportion of
each group with a 50% or greater reduction in pain (P.4566,
P.1520).
Conclusions: This preliminary data does not show that LTFESI is
less effective for the higher BMI groups compared with normal BMI
cohorts for the treatment of lumbosacral radicular pain. However,
our sample size was not large enough to find a significant difference
at a power of 80%. A larger study is needed to confirm whether BMI
is a prognostic indicator for outcomes of LTFESI for lumbosacral
radicular pain.
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Objective: To quantify pain-related impairments (PRI) of indi-
viduals with Polytrauma history 2 years and chronic nonmalig-
nant pain (CNP) by using the self-reported Ratings Determining
Impairment Associated with Pain (RDIP), obtained from the AMA
Guides 5th Edition and to investigate the correlation between PRI
and clinician-derived Physical Performance Test (PPT) scores.
Design: Retrospective cross-sectional study.
Setting: Medicare-accredited Comprehensive Outpatient Rehabil-
itation Facility (CORF).
Participants: 33 participants with polytrauma reporting CNP
(ages, 22-78 years).
Interventions: None.
Main Outcome Measures: The Self-Administered Co-Mor-
bidity Questionnaire identified individuals afflicted with CNP. The
RDIP identified PRI via 5 subscales: Pain Severity; Activity Interfer-
ence; Mood Effect; Global Pain Behavior; and, Credibility; it was cate-
gorized as: no PRI (0-6), mild (7-24), moderate (25-42), moderately
severe (43-60), and severe PRI (61-80). The PPTs were 6-MinuteWalk
(6MWT), Berg Balance Scale (BBS), and Dynamic Gait Index (DGI).
Pearson correlation coefficients (r) examined associations between
RDIP and PPT. An  of .10 was used for statistical tests.
Results: Total RDIP resulted in 0% mild PRI, 21% moderate,
33.33% moderately severe, and 45.45% severe PRI. Neither age
(F1.619, P.168) nor gender (F0.717, P.710) were signifi-
cant factors. A statistically significant negative correlation was found
between total RDIP versus BBS (r  –.480, P.005), DGI (r 
–.573, P.001), 6MWT distance (r –.506, P.003), and 6MWT
Metabolic Equivalents (r  –.511, P.002).
Conclusions: The majority scored in moderately severe to severe
PRI categories. The PRI severity had statistically significant negative
effects on PPT scores. These findings suggest that the self-reported
RDIP is a reliable indicator of physical performance and valuable as
an alternative to PPT in a busy clinical practice.
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Objective: The purpose of this study is to evaluate the efficacy of
combining a transforaminal epidural steroid injection (TFESI) with
intra-articular facet injection to improve pain and functional outcomes.
We hypothesize a synergistic effect on reduction of pain and dysfunc-
tion when using this interventional approach, because lateral recess
stenosis is most often caused by facet hypertrophic changes.
Design: This is a retrospective analysis of a preexisting data set of
1050 patients. Among inclusion criteria, subjects must have under-
gone a lumbosacral TFESI for which they completed a pre- and postin-
jection questionnaire. Our 2 cohorts include those who received lum-
bosacral TFESI alone and those that received a simultaneous intra-
articular facet joint injection at the same level. Cohorts are further
categorized based on their severity of lateral recess stenosis.
Setting: Tertiary care center.
Participants: Preexisting data set from the Spine Program Injec-
tions Quality Improvement database at the University of Michigan.
Interventions: This is a retrospective review, with no new inter-
vention. Participants in the data set received various spine interven-
tions that were clinically indicated.
Main Outcome Measures: The database includes responses
to pre- and postinjection questionnaires from patients who received
injections at the University of Michigan Spine Center from 2006-
2009. The preinjection data include demographic data, work status,
functional activities, and VAS pain scores. The postinjection data
include those questions asked in the preinjection questionnaire
along with injection satisfaction.
Results: To date, we have preliminary data; however, initial review
shows promising results for improved pain and functional out-
comes when combining transforaminal epidural steroid and intra-
articular facet injections for patients with symptomatic lumbosacral
radicular pain.
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Conclusions: Combined transforaminal epidural steroid injec-
tions and facet joint injections may be more beneficial in patients
with symptomatic lumbosacral radiculopathy than TFESI alone,
particularly in those with lateral recess stenosis caused by facet
hypertrophy.
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Objective: To compare the accessibility and the effect of retrodiskal
(RD) approach of lumbar transforaminal epidural block with conven-
tional subpediular (SP) approach in severe foraminal stenosis.
Design: Case control study.
Setting: Tertiary hospital.
Participants: Patients with L5 radiculopathy who were planned
to receive transforaminal epidural block were consecutively in-
cluded as subjects and were randomly divided into the RD group
and the SP group.
Interventions: A mixture of triamcinolone 20 mg and 0.5% lido-
caine 1.5 mL was injected in both groups after confirming a contrast
spread by retrodiskal approach through L5-S1 foramen at interver-
tebral disk level on prone position 40°-45° off the AP axis.
Main Outcome Measures: The diffusion pattern of contrast
dye, easiness of needle’s target attainment, and visual analog scale
(VAS), which had been recorded before and after 2 weeks of the
treatment, of the 2 groups.
Results: There were no differences in subjects’ demographic data
and early VAS of the RD (n13) and SP (n8) groups, which were
6.90.8 and 6.60.7, respectively. After 2 weeks of treatment, VAS
of the RD group was 2.40.9, much lower than 3.80.7 of the SP
group (P.05). We failed to insert the needle tip into the target
point in 3 patients of the SP group due to severe foraminal stenosis.
In the SP group, 2 patients had nerve root irritation symptoms
during the procedure. In 10 cases of the RD group and 4 cases of the
SP group, contrast dye diffused to the proximal nerve root, and, in
5 cases of the RD group and 3 cases of SP group, contrast dye
diffused to the distal nerve root, but there was no significant
difference between the 2 groups except for failed approach.
Conclusions: The RD approach of lumbar transforaminal epidu-
ral blockmight be a useful technique, especially in the case of severe
foraminal stenosis.
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Objective: The purpose of this study is to test the effectiveness of
a bedside clinical tool known as the Complex Regional Pain Syn-
drome (CRPS) Severity Score (CSS) as a means of tracking disease
progression of CRPS.
Design: Prospective study.
Setting: Urban outpatient pain research center.
Participants: 9 subjects.
Interventions: The CSS describes symptoms (4 items) and signs
(4 items), based on the IASP “Budapest” diagnostic criteria for CRPS,
and was used to evaluate subjects over 2 visits (2-4 months apart).
Subjects provided written consent and completed questionnaires to
detail their pain, emotional state and functional status. A physician
evaluated each patient by using the CSS.
Main Outcome Measures: Patient Global Impression of
Change (PGIC), McGill Pain Questionnaire-Short Form (MPQ-SF),
Visual Analog Scale (VAS), Numerical Rating Scale (NRS), Center
for Epidemiologic Studies Depression Scale (CES-D), Pain Disability
Index (PDI), Pain Anxiety Symptoms Scale (PASS-20), and Occu-
pational Status Questionnaire (OSQ).
Results: Data were analyzed by using the Spearman correlation to
identify relationships between changes in the CSS and changes in
the outcome measures. The following were found to be strong
correlations with significance: Positive relationship of 	CSS and
	Signs of CSS, positive relationship of 	CSS and 	CES-D. The
following were found to be strong correlations that approached
significance: positive relationship of 	CSS and 	Symptoms of CSS,
positive relationship of 	Signs of CSS and 	VAS, positive relation-
ship of 	Signs of CSS and 	CES-D, positive relationship of
	Symptoms of CSS and 	CES-D.
Conclusions: The CSS may prove to be a quick and effective
clinical bedside tool formonitoring the subtleties of CRPS status and
evolution, as a complement to dichotomous diagnostic criteria.
Future validation research will involve additional measures (such as
the Short Form 36 for quality of life), larger subject pool from
international sites (eg, Canada, United Kingdom, Germany, Japan,
Israel, The Netherlands), and to evaluate the utility of CSS for
responsiveness to change and treatment of CRPS.
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Patients or Programs: A 47-year-old woman with a history of
C3 human immunodeficiency virus (HIV) and chronic low back
pain.
Program Description: The patient presented to clinic with a
history of chronic low back pain and radiation into the posterior leg
and toes with magnetic resonance imaging evidence of a lumbar
disk extrusion. She had undetectable HIV RNA levels on a regimen
that included a protease inhibitor boosted with ritonavir and 2
nucleoside reverse transcriptase inhibitors. After failing more con-
servative options, the patient received 3 epidural steroid injections
with triamcinolone (80 mg) at 5-month intervals. During routine
follow-up, she was found to have a prominent buffalo hump,
supraclavicular fat pads, facial swelling, violaceous abdominal
striae, and elevated glucose levels. An endocrine workup revealed
very low urine and serum cortisol levels (1.1 mcg per 24 hours,
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